TCBPW Short Term Debt from 2010 to 2024

TCBPW Stock  USD 0.02  0  24.67%   
TC BioPharm Short Term Debt yearly trend continues to be fairly stable with very little volatility. Short Term Debt will likely drop to about 290.1 K in 2024. During the period from 2010 to 2024, TC BioPharm Short Term Debt regression line of quarterly data had mean square error of 3.4 T and geometric mean of  512,159. View All Fundamentals
 
Short Term Debt  
First Reported
2010-12-31
Previous Quarter
305.3 K
Current Value
290.1 K
Quarterly Volatility
1.8 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check TC BioPharm financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among TC BioPharm's main balance sheet or income statement drivers, such as Interest Income of 1.9 K, Depreciation And Amortization of 638 K or Interest Expense of 78.9 K, as well as many indicators such as Price To Sales Ratio of 0.62, Dividend Yield of 0.0 or PTB Ratio of 0.3. TCBPW financial statements analysis is a perfect complement when working with TC BioPharm Valuation or Volatility modules.
  
Check out the analysis of TC BioPharm Correlation against competitors.

Latest TC BioPharm's Short Term Debt Growth Pattern

Below is the plot of the Short Term Debt of TC BioPharm plc over the last few years. It is TC BioPharm's Short Term Debt historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in TC BioPharm's overall financial position and show how it may be relating to other accounts over time.
Short Term Debt10 Years Trend
Pretty Stable
   Short Term Debt   
       Timeline  

TCBPW Short Term Debt Regression Statistics

Arithmetic Mean915,858
Geometric Mean512,159
Coefficient Of Variation201.77
Mean Deviation896,236
Median414,630
Standard Deviation1,847,946
Sample Variance3.4T
Range7.3M
R-Value0.26
Mean Square Error3.4T
R-Squared0.07
Significance0.35
Slope107,215
Total Sum of Squares47.8T

TCBPW Short Term Debt History

2024290.1 K
2023305.3 K
2022981.5 K
20217.6 M
2020442.7 K

About TC BioPharm Financial Statements

TC BioPharm investors use historical fundamental indicators, such as TC BioPharm's Short Term Debt, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in TC BioPharm. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Short Term Debt305.3 K290.1 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for TCBPW Stock Analysis

When running TC BioPharm's price analysis, check to measure TC BioPharm's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TC BioPharm is operating at the current time. Most of TC BioPharm's value examination focuses on studying past and present price action to predict the probability of TC BioPharm's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TC BioPharm's price. Additionally, you may evaluate how the addition of TC BioPharm to your portfolios can decrease your overall portfolio volatility.